Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colchicine in patients with non-ST-elevation myocardial infarction
IRCT20190601043780N1Phase 3Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Jun 2019
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, double-blind trial of colchicine in Non-ST-segment elevation myocardial infarction (NSTEMI) (2 arms), sponsored by Mashhad University of Medical Sciences. Primary endpoint: high sensitive CRP. Started Jun 2019; status: completed.
02
Drugs
colchicine
03
Conditions
Non-ST-segment elevation myocardial infarction (NSTEMI)
Beyond the preview
Go deeper on IRCT20190601043780N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20190601043780N1.